Impaired antibody response to inactivated COVID-19 vaccines in hospitalized patients with type 2 diabetes

Impaired antibody response to inactivated COVID-19 vaccines in hospitalized patients with type 2 diabetes

Patients with type 2 diabetes (T2D) are at an increased risk of morbidity and mortality of coronavirus disease 2019 (COVID-19). Data on the antibody response to COVID-19 vaccines in T2D patients are less studied. This study aimed to evaluate IgG antibody response to inactivated COVID-19 vaccines in...

Full description

Bibliographic Details
Main Authors: Xiaoying Zhou, Huixia Lu, Miaomiao Sang, Shanhu Qiu, Yang Yuan, Tongzhi Wu, Junhao Chen, Zilin Sun
Format: Article
Language:English
Published: Taylor & Francis Group 2023-01-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
type 2 diabetes
covid-19
vaccine
seropositivity
Online Access:http://dx.doi.org/10.1080/21645515.2023.2184754

Internet

http://dx.doi.org/10.1080/21645515.2023.2184754

Similar Items